Αποτελέσματα Αναζήτησης
The guideline provides updated evidence-based or best clinical practice information regarding the diagnosis and subsequent management of nausea and vomiting in pregnancy (NVP) and hyperemesis gravidarum (HG) across community, ambulatory day care and inpatient settings.
6 Φεβ 2024 · This comprehensive update sets out best practice to ensure that all women and pregnant people can access supportive care and counselling in the most appropriate setting, based on evidence-led investigations and treatment options.
What therapeutic options are available for NVP and HG? What is the safety and efficacy of pharmacological agents? Antiemetics. There are safety and efficacy data for first-line antiemetics such as antihistamines (H1 receptor antagonists) and phenothiazines and they should be prescribed when required for NVP and HG (Appendix III).
4 Φεβ 2024 · There is variation in the care of women who have nausea and vomiting of pregnancy (NVP) or hyperemesis gravidarum (HG) with the potential for lack of understanding of its severity and options for treatment and support.
For pregnancies at more than 16 weeks of gestation the term low-lying placenta should be D used when the placental edge is less than 20 mm from the internal os on transabdominal or transvaginal scanning (TVS). [ ] New 2018.
9 Αυγ 2022 · The clinical issues for women and pregnant people with ICP may include coping with the itching, monitoring options during the pregnancy, options for controlling maternal symptoms, reducing fetal risk, preterm birth, difficulty sleeping, anxiety about the condition, and optimal timing of birth.
19 Αυγ 2021 · 1.1.1. Ensure that antenatal care can be started in a variety of straightforward ways, depending on women's needs and circumstances, for example, by self-referral, referral by a GP, midwife or another healthcare professional, or through a school nurse, community centre or refugee hostel. 1.1.2. At the point of antenatal care referral:
